World's Best Scientists 2026 revealed!
Jean-François Dufour

Jean-François Dufour

D-Index & Metrics

Medicine

D-Index
87
Citations
36922
World Ranking
13453
National Ranking
190

Overview

Jean-François Dufour is affiliated with the University of Bern in Switzerland. Their research primarily focuses on the field of Medicine with extensive contributions to subfields including Epidemiology, Hepatology, Molecular Biology, Oncology, and Surgery.

The scientist has published numerous articles addressing various topics within liver disease research. Their main areas of work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Liver Diseases and Immunity
  • Diet, Metabolism, and Disease
  • Alcohol Consumption and Health Effects

Jean-François Dufour's recent notable papers include:

  • "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement," 2020, Journal of Hepatology
  • "NASH limits anti-tumour surveillance in immunotherapy-treated HCC," 2021, Nature
  • "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort," 2020, Journal of Hepatology
  • "Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH," 2021, Nature
  • "Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests," 2021, Nature Reviews Gastroenterology & Hepatology

The frequent co-authors collaborating with Jean-François Dufour include:

  • Quentin M. Anstee
  • Pompilia Radu
  • Vlad Ratziu
  • Jörn M. Schattenberg
  • Elisabetta Bugianesi

Regarding publication venues, the scientist regularly contributes to several journals, with the highest number of publications appearing in:

  • Journal of Hepatology
  • Gut
  • Cancers
  • Liver International
  • Zeitschrift für Gastroenterologie

Best Publications

  • EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

    Giulio Marchesini;Christopher P. Day;Jean Francois Dufour;Ali Canbay

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

    Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee

  • Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

    Adriaan J. van der Meer;Bart J. Veldt;Jordan J. Feld;Heiner Wedemeyer

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

    Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

    Luigi Bolondi;Andrew Burroughs;Jean François Dufour;Peterr R. Galle

  • Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

    Stuart McPherson;Stuart McPherson;Tim Hardy;Tim Hardy;Jean-Francois Dufour;Salvatore Petta

  • TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    Yang-Lin Liu;Helen L Reeves;Alastair D Burt;Dina Tiniakos

  • Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    Michael Manns;Didier Samuel;Edward J Gane;David Mutimer

  • Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma

    Y-L Liu;G L Patman;J B S Leathart;Anne Christine Piguet

  • Angiogenesis and hepatocellular carcinoma

    David Semela;Jean-François Dufour

  • Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid With Vitamin E in Nonalcoholic Steatohepatitis

    Jean–François Dufour;Carl M. Oneta;Jean–Jacques Gonvers;Florian Bihl

  • Auto-aggressive CXCR6 + CD8 T cells cause liver immune pathology in NASH

    Michael Dudek;Dominik Pfister;Sainitin Donakonda;Pamela Filpe

  • Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

    Mojgan Masoodi;Amalia Gastaldelli;Tuulia Hyötyläinen;Enara Arretxe

  • Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis

    Jean-Francois Dufour;Ronald DeLellis;Marshall M. Kaplan

  • Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

    Pierre-Yves Bochud;Pierre-Yves Bochud;Tao Cai;Tao Cai;Kathrin Stéphanie Overbeck;Murielle Bochud

  • Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort.

    Quentin M. Anstee;Quentin M. Anstee;Rebecca Darlay;Simon Cockell;Marica Meroni

  • Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.

    David Semela;Anne-Christine Piguet;Mirjam Kolev;Karin Schmitter

  • Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.

    Andrew D. Patterson;Olivier Maurhofer;Diren Beyoğlu;Christian Lanz

  • Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.

    Christian Toso;Glenda Meeberg;Roberto Hernandez-Alejandro;Jean-François Dufour

Frequent Co-Authors

Quentin M. Anstee
Quentin M. Anstee Newcastle University
Francesco Negro
Francesco Negro University of Geneva
Zoltán Kutalik
Zoltán Kutalik University of Lausanne
Darius Moradpour
Darius Moradpour University of Lausanne
Markus H. Heim
Markus H. Heim University Hospital of Basel
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Andreas Cerny
Andreas Cerny University of Bern
Pierre-Yves Bochud
Pierre-Yves Bochud University of Lausanne
Josep M. Llovet
Josep M. Llovet University of Barcelona
Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in alternative or complementary career pathways in healthcare, there are many accredited online degree options beyond the traditional MD route. Seeking out programs with strong accreditation is essential. For example, there are which online healthcare degree programs are recognized for their accreditation by cahme? to ensure you’re choosing quality programs that meet industry standards.

Many licensed nurses looking to advance their education now opt for flexible formats. There are high-quality online rn to bsn no clinicals programs, which allow registered nurses to earn bachelor’s degrees entirely online, without required in-person clinical components.

For those aiming for the highest levels in nursing, you can consider short dnp programs or explore easiest dnp programs. These advanced degrees can lead to leadership positions, clinical practice roles, or careers in healthcare administration.

Exploring these specialized online programs can open diverse and rewarding career opportunities across the US healthcare system—all while accommodating your schedule.

Best Scientists Citing Jean-François Dufour

Trending Scientists